However, more recently, using an alternative mouse model with stochastic loss of heterozygosity of TP53, tumor cell lines, and genetically-characterized patient-derived xenografts, Yang A. et al. [114] showed that p53 status does not seem to affect response to autophagy inhibition. Here, TP53 is linked to neoplasm.